Health And Medicine

A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation. Read More

Studies of a human polymerase that replicates DNA have provided a complete kinetic and structural framework for understanding how the enzyme accurately bypasses DNA damage. Read More

A novel PET imaging probe detects tumor cell death in vivo and could be useful for personalizing cancer medicine. Read More

The prosthetics research of Michael Goldfarb is featured in "The NBIB Bionic Man," an interactive web tool that helps students and the public learn about innovative federally-funded biomedical research. Read More

(Vanderbilt University) Potentially “game-changing” research at Vanderbilt University on infectious diseases, population health and health policy will be showcased during two interactive presentations May 15 and May 22. A segment of the Flexner Discovery Lecture Series, the new “Vanderbilt Cutting-edge Discovery” discussions are highlights of recent presentations… Read More

A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication. Read More

Understanding how chikungunya virus binds to and enters cells offers a new target for antiviral medications. Read More

Having a “leaky” gut may protect against colitis, a paradoxical finding that alters understanding of the role of cell permeability in intestinal homeostasis and immune regulation. Read More

Tremor is the most common of all movement disorders and its involuntary nature can hinder an individual’s ability to dress or feed themselves, use a phone or computer, or engage in chores and hobbies. Read More

Dynamic measurements of the bacterial leucine transporter shed light on the transporters that play roles in neuropsychiatric and addiction disorders. Read More

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and Donna S. Hall Professor of Breast Cancer Research at Vanderbilt-Ingram Cancer Center (VICC), assumed the presidency of the American Association for Cancer Research (AACR) for 2014-2015 during the group’s annual meeting last week in San Diego. Read More

Vanderbilt University researchers have discovered how intestinal cells build the "brush border" -- a specialized surface structure that is critical for absorbing nutrients and defending against pathogens. Read More

A new compound that activates potassium channels could be used to treat disorders of glucose homeostasis. Read More

Vanderbilt researchers have identified a new signaling system that anthrax bacteria uses to infect its host. Read More

A protein in the myelin coating on nerves helps form a “seal” that enables effective nerve conduction; loss of the protein causes inherited neuropathies. Read More

Researchers at Vanderbilt University have identified a potential new drug target in subtypes of lung cancer that are difficult to treat. Read More

The extracellular matrix that surrounds cells plays a role in the development of insulin resistance. Read More

A long-term Vanderbilt University Medical Center study of deep brain stimulation (DBS) in early-stage Parkinson’s disease has received approval from the Food and Drug Administration (FDA) to continue in a pivotal, phase III, large-scale safety and efficacy trial. Read More

One of the most formidable weapons in a cancer’s arsenal is the ability to spread to other organs. Read More

Vanderbilt University Medical Center has been selected as one of three sites to share a three-year, $1.3 million grant from the National Institutes of Health (NIH) to explore the potential therapeutic properties of manganese, a chemical element and biologically essential trace mineral, in treating Restless Legs Syndrome (RLS). Read More